Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort.
Simon D, Tascilar K, Kleyer A, Fagni F, Krönke G, Meder C, Dietrich P, Orlemann T, Kliem T, Mößner J, Liphardt AM, Schönau V, Bohr D, Schuster L, Hartmann F, Leppkes M, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Hueber AJ, Manger K, Manger B, Atreya R, Berking C, Sticherling M, Neurath MF, Schett G. Simon D, et al. Among authors: bohr d. Arthritis Rheumatol. 2022 May;74(5):783-790. doi: 10.1002/art.42035. Epub 2022 Mar 23. Arthritis Rheumatol. 2022. PMID: 34951137 Free PMC article.
Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trial.
Knitza J, Mohn J, Bergmann C, Kampylafka E, Hagen M, Bohr D, Morf H, Araujo E, Englbrecht M, Simon D, Kleyer A, Meinderink T, Vorbrüggen W, von der Decken CB, Kleinert S, Ramming A, Distler JHW, Vuillerme N, Fricker A, Bartz-Bazzanella P, Schett G, Hueber AJ, Welcker M. Knitza J, et al. Among authors: bohr d. Arthritis Res Ther. 2021 Apr 13;23(1):112. doi: 10.1186/s13075-021-02498-8. Arthritis Res Ther. 2021. PMID: 33849654 Free PMC article. Clinical Trial.
Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination.
Fagni F, Schmidt K, Bohr D, Valor-Méndez L, Hartmann F, Tascilar K, Manger K, Manger B, Kleyer A, Simon D, Schett G, Harrer T. Fagni F, et al. Among authors: bohr d. RMD Open. 2022 May;8(1):e002323. doi: 10.1136/rmdopen-2022-002323. RMD Open. 2022. PMID: 35589333 Free PMC article. No abstract available.
Non-invasive metabolic profiling of inflammation in joints and entheses by multispectral optoacoustic tomography.
Tascilar K, Fagni F, Kleyer A, Bayat S, Heidemann R, Steiger F, Krönke G, Bohr D, Ramming A, Hartmann F, Klett D, Federle A, Regensburger AP, Wagner AL, Knieling F, Neurath MF, Schett G, Waldner M, Simon D. Tascilar K, et al. Among authors: bohr d. Rheumatology (Oxford). 2023 Feb 1;62(2):841-849. doi: 10.1093/rheumatology/keac346. Rheumatology (Oxford). 2023. PMID: 35699479
Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study.
Simon D, Tascilar K, Fagni F, Kleyer A, Krönke G, Meder C, Dietrich P, Orlemann T, Mößner J, Taubmann J, Mutlu MY, Knitza J, Kemenes S, Liphardt AM, Schönau V, Bohr D, Schuster L, Hartmann F, Minopoulou I, Leppkes M, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Hueber AJ, Manger K, Manger B, Atreya R, Berking C, Sticherling M, Neurath MF, Schett G. Simon D, et al. Among authors: bohr d. Lancet Rheumatol. 2022 Sep;4(9):e614-e625. doi: 10.1016/S2665-9913(22)00191-6. Epub 2022 Aug 9. Lancet Rheumatol. 2022. PMID: 35966645 Free PMC article.
Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based study.
Fuchs F, Morf H, Mohn J, Mühlensiepen F, Ignatyev Y, Bohr D, Araujo E, Bergmann C, Simon D, Kleyer A, Vorbrüggen W, Ramming A, Distler JHW, Bartz-Bazzanella P, Schett G, Welcker M, Hueber AJ, Knitza J. Fuchs F, et al. Among authors: bohr d. Rheumatol Int. 2023 Mar;43(3):495-502. doi: 10.1007/s00296-022-05223-z. Epub 2022 Oct 10. Rheumatol Int. 2023. PMID: 36214864 Free PMC article.
Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study.
Minopoulou I, Tascilar K, Corte G, Mutlu MY, Schmidt K, Bohr D, Hartmann F, Manger K, Manger B, Korn K, Kleyer A, Simon D, Harrer T, Schett G, Fagni F. Minopoulou I, et al. Among authors: bohr d. Rheumatology (Oxford). 2024 May 2;63(5):1377-1383. doi: 10.1093/rheumatology/kead391. Rheumatology (Oxford). 2024. PMID: 37531288
[CAR T-cell therapy in rheumatology-What we know so far?].
Hagen M, Wirsching A, Bohr D, Taubmann J, Müller F, Mackensen A, Grieshaber-Bouyer R, Schett G. Hagen M, et al. Among authors: bohr d. Z Rheumatol. 2024 Aug;83(6):485-491. doi: 10.1007/s00393-024-01514-x. Epub 2024 May 23. Z Rheumatol. 2024. PMID: 38780637 Free PMC article. Review. German.
226 results